• About Us
    • Our Story
    • Values & Commitment
    • Our Process
    • Meet the Team
    • Our Partners
  • Compliance Services
    • Cell & Gene Therapy
    • Pharmaceutical Drugs
    • Medical Devices
    • FDA 483 / Warning Letter
    • US Agent & Official Correspondent
    • Audits
    • Compliance Without the Attorney Fees
    • Dietary Supplement
    • Facility Registration & Listing
    • FDA Compliance
    • Good Supply Practice
    • Modernization of Cosmetics Regulation Act
    • Quality Culture
    • Quality Management System Regulation
    • Peptides
    • Product Recalls
    • Quality Systems
    • Regulatory Affairs
    • Training
    • Virtual Quality Assurance
  • Expertise
    • Pharmaceutical
    • Medical Devices
    • Clinical
    • Biologics
  • Resources
    • Compliance Insight Blog
    • GXP Infusion
    • Quality Assurance Accreditation
    • Success Stories
    • Videos and Media
    • White Papers And Downloads
  • Search
  • Contact
Compliance Insight
Skip to content
  • About Us
    • Our Story
    • Values & Commitment
    • Our Process
    • Meet the Team
    • Our Partners
  • Compliance Services
    • Cell & Gene Therapy
    • Pharmaceutical Drugs
    • Medical Devices
    • FDA 483 / Warning Letter
    • US Agent & Official Correspondent
    • Audits
    • Compliance Without the Attorney Fees
    • Dietary Supplement
    • Facility Registration & Listing
    • FDA Compliance
    • Good Supply Practice
    • Modernization of Cosmetics Regulation Act
    • Quality Culture
    • Quality Management System Regulation
    • Peptides
    • Product Recalls
    • Quality Systems
    • Regulatory Affairs
    • Training
    • Virtual Quality Assurance
  • Expertise
    • Pharmaceutical
    • Medical Devices
    • Clinical
    • Biologics
  • Resources
    • Compliance Insight Blog
    • GXP Infusion
    • Quality Assurance Accreditation
    • Success Stories
    • Videos and Media
    • White Papers And Downloads
  • Search
  • Contact

Blog

Share
  • Facebook
  • Twitter
  • LinkedIn
  • Email

February 4, 2020by TLM

FDA published a revision to MAPP

January 28, 2020by TLM

Public meeting announcement..

January 21, 2020by TLM

Are you worried about the US Hemp rules??

January 18, 2020by TLM

Congratulations Compliance Insight!!

January 16, 2020by TLM

Data Integrity and GMP’s

November 13, 2019by TLM

The FDA is sending out a warning about Biotin

November 5, 2019by TLM

Did you know this about hemp??

October 31, 2019by TLM

CBD and dinner? You bet!

October 2, 2019by TLM

Don’t miss out on our President Cynthia Ipach speaking at LaunchBio! You won’t want to miss it!

October 1, 2019by TLM

What a SUCCESS!!

September 18, 2019by TLM

Good Supply Practices, what you need to know!

September 3, 2019by TLM

Do you know that NIPP includes quality culture?

August 28, 2019by TLM

Ohio Governor signs hemp legalization bill

August 27, 2019by TLM

Do you know what the FDA has to say about Good Supply Practices??

August 27, 2019by TLM

Things are changing!

August 22, 2019by TLM

Am I Behind? How AI is being used in industry

August 20, 2019by TLM

Are you legally selling CBD products?

August 14, 2019by TLM

Are you interested in a 2 day workshop on Good Supply Practices?

August 14, 2019by TLM

The FDA has announced the user fee rates for 2020

August 13, 2019by TLM

Did you know??

March 29, 2019by TLM

FDA targeting CBD marketers of over the line claims

  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
  • Next Page »

Be in Touch

info@compliance-insight.com
p. 513-860-3512

Corporate Headquarters

497 Circle Freeway Suite 230
Cincinnati, Ohio 45246

Business Hours

Monday – Friday
8:30am EST – 5:30pm EST

Social

© 2025 by Compliance Insight All Rights Reserved | Contact Us

Privacy Policy | Terms of Use | Use of Cookies